Results from this analysis are consistent with prior knowledge of EGFR-mutant NSCLC, demonstrating a PD-L1 low, GzmB low, IFNG low and TGFbeta high immune phenotype, suggesting a suppressive tumor microenvironment. This evidence concerns the gene GZMB and neoplasm.